|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||19.24 - 19.99|
|52-week range||16.50 - 21.51|
|Beta (5Y monthly)||0.39|
|PE ratio (TTM)||16.74|
|Forward dividend & yield||1.10 (5.69%)|
|Ex-dividend date||19 Aug 2021|
|1y target est||N/A|
GSK Consumer Healthcare (LSE/NYSE: GSK) is raising a cup – or two – of coffee to celebrate enjoying life's simple pleasures without the interruption of tooth sensitivity. Joy – something we haven't had much of throughout the pandemic – is all about feeling good in small and seemingly simple moments, but for those who suffer from sensitive teeth, something as little as enjoying a cup of coffee might not be so joyful.
LONDON, September 28, 2021--FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV
LONDON, July 29, 2021--GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps.